Literature DB >> 19671756

Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma.

Sanjeev A Vasudevan1, Xiaoying Shang, Xiaoyi Shang, Shirong Chang, Ningling Ge, Jose L Diaz-Miron, Heidi V Russell, M John Hicks, Andrew D Ludwig, Catherine L Wesson, Susan M Burlingame, Eugene S Kim, Javed Khan, Jianhua Yang, Jed G Nuchtern.   

Abstract

Secreted proteins such as growth factors, cytokines, and chemokines play important roles in tumor development. Through expression microarray and bioinformatic analysis, we discovered a novel secreted protein, neuroblastoma-derived secretory protein (NDSP). The NDSP gene is found on chromosome 1q25.2 and encodes a 167 amino acid protein with a putative signal peptide. Using real-time PCR and immunoblotting, we find that NDSP is specifically overexpressed in neuroblastoma at much higher levels than other adult and pediatric malignancies and normal tissues. NDSP is an 18-kDa protein that can be secreted by NDSP-transfected HEK-293T cells, as well as, neuroblastoma cell lines endogenously expressing NDSP. Inhibiting NDSP expression in neuroblastoma cell lines with retrovirally transduced NDSP small hairpin interfering RNA, sh-NDSP, results in decreased cellular proliferation and colony formation. We also find inhibited extracellular signal-regulated kinase (ERK)1/2 phosphorylation in the sh-NDSP cell line. Treating the parental cell line with MAP/ERK kinase 1/2 inhibitors, which diminish ERK1/2 phosphorylation, results in decreased cell proliferation. Culturing these transduced cells with recombinant NDSP, reintroducing NDSP overexpression in the knockdown cell line, or inducing Ras oncogene overexpression for constitutive ERK1/2 activation results in a reversal of the growth-inhibited phenotype and proliferation rates similar to the control cells. In addition, reintroduction of NDSP overexpression in the sh-NDSP cell line results in ERK1/2 phosphorylation similar to control. We conclude that NDSP is specifically overexpressed in neuroblastoma and actively secreted from tumor cells. Furthermore, NDSP serves as a growth factor for neuroblastoma tumor cells through activation of the ERK-mediated proliferation pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671756      PMCID: PMC3618953          DOI: 10.1158/1535-7163.MCT-08-1132

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  35 in total

1.  Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis.

Authors:  Craig C Whiteford; Sven Bilke; Braden T Greer; Qingrong Chen; Till A Braunschweig; Nicola Cenacchi; Jun S Wei; Malcolm A Smith; Peter Houghton; Christopher Morton; C Patrick Reynolds; Richard Lock; Richard Gorlick; Chand Khanna; Carol J Thiele; Mikiko Takikita; Daniel Catchpoole; Stephen M Hewitt; Javed Khan
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

2.  Insulin-like growth factor I stimulates motility in human neuroblastoma cells.

Authors:  G E Meyer; E Shelden; B Kim; E L Feldman
Journal:  Oncogene       Date:  2001-11-08       Impact factor: 9.867

Review 3.  Neuroblastoma: biological insights into a clinical enigma.

Authors:  Garrett M Brodeur
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

4.  Integrin expression regulates neuroblastoma attachment and migration.

Authors:  Amy Meyer; Cynthia M van Golen; Bhumsoo Kim; Kenneth L van Golen; Eva L Feldman
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

5.  Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis.

Authors:  Mauricio J Reginato; Kenna R Mills; Jessica K Paulus; Danielle K Lynch; Dennis C Sgroi; Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

6.  Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.

Authors:  Sirith Douma; Theo Van Laar; John Zevenhoven; Ralph Meuwissen; Evert Van Garderen; Daniel S Peeper
Journal:  Nature       Date:  2004-08-26       Impact factor: 49.962

Review 7.  Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapse.

Authors:  L Raffaghello; D Marimpietri; G Pagnan; F Pastorino; E Cosimo; C Brignole; M Ponzoni; P G Montaldo
Journal:  Cancer Lett       Date:  2003-07-18       Impact factor: 8.679

Review 8.  Fenretinide as an anti-angiogenic agent in neuroblastoma.

Authors:  Domenico Ribatti; Lizzia Raffaghello; Danilo Marimpietri; Emilio Cosimo; P Giuseppe Montaldo; Beatrice Nico; Angelo Vacca; Mirco Ponzoni
Journal:  Cancer Lett       Date:  2003-07-18       Impact factor: 8.679

9.  N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells.

Authors:  Daniel Noujaim; Cynthia M van Golen; Kenneth L van Golen; Alyssa Grauman; Eva L Feldman
Journal:  Oncogene       Date:  2002-07-04       Impact factor: 9.867

10.  The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin.

Authors:  Lisa M Butler; Xianbo Zhou; Wei-Sheng Xu; Howard I Scher; Richard A Rifkind; Paul A Marks; Victoria M Richon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-20       Impact factor: 11.205

View more
  6 in total

1.  Genome-wide linkage and association analysis of cardiometabolic phenotypes in Hispanic Americans.

Authors:  Jacklyn N Hellwege; Nicholette D Palmer; Latchezar Dimitrov; Jacob M Keaton; Keri L Tabb; Satria Sajuthi; Kent D Taylor; Maggie C Y Ng; Elizabeth K Speliotes; Gregory A Hawkins; Jirong Long; Yii-Der Ida Chen; Carlos Lorenzo; Jill M Norris; Jerome I Rotter; Carl D Langefeld; Lynne E Wagenknecht; Donald W Bowden
Journal:  J Hum Genet       Date:  2016-08-18       Impact factor: 3.172

2.  Identification of an eight-gene signature for survival prediction for patients with hepatocellular carcinoma based on integrated bioinformatics analysis.

Authors:  Guo-Jie Qiao; Liang Chen; Jin-Cai Wu; Zhou-Ri Li
Journal:  PeerJ       Date:  2019-03-20       Impact factor: 2.984

3.  BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma.

Authors:  Yan-Ling Chen; Xiao-Lu Li; Gen Li; Yan-Fang Tao; Ran Zhuo; Hai-Bo Cao; Wan-Yan Jiao; Zhi-Heng Li; Zhen-Hong Zhu; Fang Fang; Yi Xie; Xin-Mei Liao; Di Wu; Hai-Rong Wang; Juan-Juan Yu; Si-Qi Jia; Yang Yang; Chen-Xi Feng; Peng-Cheng Yang; Xiao-Dong Fei; Jian-Wei Wang; Yun-Yun Xu; Guang-Hui Qian; Zi-Mu Zhang; Jian Pan
Journal:  Cell Biosci       Date:  2022-03-18       Impact factor: 7.133

4.  Unknown genes, Cebelin and Cebelin-like, predominantly expressed in mouse brain.

Authors:  Hiroyuki Miwa; Nobuyuki Itoh
Journal:  Heliyon       Date:  2018-09-06

5.  FAM163A, a positive regulator of ERK signaling pathway, interacts with 14-3-3β and promotes cell proliferation in squamous cell lung carcinoma.

Authors:  Nan Liu; Haijing Zhou; Xiupeng Zhang; Lin Cai; Jingduo Li; Jing Zhao; Yang Liu; Liang Wang; Chuifeng Fan; Ailin Li; Yuan Miao
Journal:  Onco Targets Ther       Date:  2019-08-13       Impact factor: 4.147

6.  USP22 promotes development of lung adenocarcinoma through ubiquitination and immunosuppression.

Authors:  Bing Han; Yue Sun; Dongdong Yang; Huijuan Zhang; Steven Mo; Xuesong Chen; Hailing Lu; Xueyan Mao; Jing Hu
Journal:  Aging (Albany NY)       Date:  2020-04-15       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.